July 15, 2022
Via: PharmaphorumThe PureTech group company – which scored the first FDA and EMA approvals for a DTx for attention-deficit hyperactivity disorder (ADHD) – is developing AKL-T01 to tackle cognitive impairments that can affect people with SLE. Cognitive dysfunction occurs in between […]
December 7, 2023
December 5, 2023
November 30, 2023
November 28, 2023
November 13, 2023
November 16, 2023